2Nemunaitis J, Cunningham C, Buchanan A, et al. Intravenous infusion of a replication-selective adenovirus (ONYX-OIS) in cancer patients: safety, feasibility and biological activity. C, ene Ther 2001:8(10):746 - 59.
3Kirn D. Clinical research results with dl1520(Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? Gene Ther 2001;8(2):89 - 98.
4Prince GA. Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hisDidus). J Virol 1993: 67:101 - 11.
5Curlel DT. Strategies to adapt adenoviral vectors for targeted delivery. Ann NY Acad Sci 1999: 886:158 -71.
6Duncan, SJ. Infection of mouse liver by human adenovirus type 5, J Gen Birol 1978; 40:45 - 61.
7Springer CJ, Niculescu-Duvaz I. Prodrug-activating systems in suicide gene therapy. J Clin Invest 2000; 105:1161 -7.
8Matzinger P, Tolerance. danger,and the extended family. Annu Rev Immunol 1994;12:991 - 1045.
